🔎 Trials Near Me

Home › Neuroblastoma › Texas › Dallas

Neuroblastoma clinical trials in Dallas, TX

10 studies for Neuroblastoma are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Recruiting
  • University of Texas Southwestern Medical Center, Dallas
Up to age 17 · All sexes · Updated Nov 13, 2026 · NCT06831552

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

RecruitingPhase 1/2
  • Children's Medical Center, Dallas
Up to age 30 · All sexes · Updated Nov 12, 2026 · NCT06541262

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RecruitingPhase 3
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Up to age 30 · All sexes · Updated Oct 30, 2026 · NCT06172296

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

RecruitingPhase 1
  • UT Southwestern, Dallas
12 Months – 20 Years · All sexes · Updated Oct 8, 2026 · NCT02013336

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

RecruitingPhase 2
  • Children's Medical Center, Dallas
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

RecruitingPhase 2
  • Children's Medical Center, Dallas
Ages 1 to 21 · All sexes · Updated Sep 3, 2026 · NCT06540963

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

RecruitingPhase 1/2
  • Children's Medical Center, Dallas
Up to age 26 · All sexes · Updated Sep 3, 2026 · NCT06465199

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RecruitingPhase 3
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

RecruitingPhase 2
  • University of Texas Southwestern, Dallas
Ages 1 to 31 · All sexes · Updated Jul 20, 2026 · NCT06450041

Neuroblastoma Biology Study

RecruitingObservational study
  • University of Texas Southwestern, Dallas
31 Days – 99 Years · All sexes · Updated Mar 23, 2026 · NCT01587300

About Neuroblastoma

Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.

More about Neuroblastoma on MedlinePlus

Neuroblastoma trials in other cities

Other studies in Dallas

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.